SCHEMBL2519974

SCHEMBL2519974

C=CCOC(=O)C(N)CCC(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
BLM P54132 2/20 0.48
ALOX15 P16050 1/20 0.48
PMP22 Q01453 1/20 0.48
MAPT P10636 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
TSHR P16473 3/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
CYP3A4 P08684 1/20 0.34
MEN1 O00255 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL795492 1.00 KMT2A (0.48) KMT2ABLMALOX15PMP22MAPT
SCHEMBL2518196 0.85 CYP2D6 (0.50) KMT2ABLMALOX15PMP22MAPT
SCHEMBL3968417 0.85 TSHR (0.47) KMT2ABLMALOX15PMP22MAPT
SCHEMBL176230 0.85 CYP2D6 (0.50) KMT2ABLMALOX15PMP22MAPT
SCHEMBL176229 0.85 TSHR (0.47) KMT2ABLMALOX15PMP22MAPT
SCHEMBL176227 0.85 TSHR (0.47) KMT2ABLMALOX15PMP22MAPT
SCHEMBL29412215 0.84 BLM (0.44) KMT2ABLMALOX15PMP22MAPT
SCHEMBL14186824 0.84 TDP1 (0.39) KMT2ABLMALOX15PMP22MAPT
SCHEMBL10972597 0.81 MAPT (0.42) KMT2AMAPTCACNA1BAPBA1TSHR
SCHEMBL7950462 0.81 TDP1 (0.39) KMT2ABLMMAPTCACNA1BAPBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030513-B2 Rheology control agents E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-10-04 US disclosed
US-20100204376-A1 Rheology Control Agents AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) 2010-08-12 US disclosed
US-7741510-B2 Rheology control agents E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-06-22 US disclosed
EP-1838749-A1 COATING COMPOSITIONS CONTAINING RHEOLOGY CONTROL AGENTS E.I.Du pont de nemours and company (US) 2007-10-03 EP disclosed
WO-2006076715-A1 COATING COMPOSITIONS CONTAINING RHEOLOGY CONTROL AGENTS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-07-20 WO disclosed
US-20060155021-A1 Coating compositions containing rheology control agents E. I. DU PONT DE NEMOURS AND COMPANY 2006-07-13 US disclosed
US-20060155146-A1 Rheology control agents AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) 2006-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060155146-A1 Rheology control agents HCRTR1, HCRTR2, REL KMT2A 2284/4885BLM 1801/4885ALOX15 1500/4885
US-20100204376-A1 Rheology Control Agents HCRTR1, HCRTR2, REL KMT2A 2284/4885BLM 1801/4885ALOX15 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.